GSA Capital Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.45M | Sell |
930,089
-66,146
| -7% | -$96.2K | 0.09% | 298 |
|
|
2025
Q4 | $1.15M | Sell |
996,235
-206,671
| -17% | -$284K | 0.1% | 288 |
|
|
2025
Q3 | $1.62M | Sell |
1,202,906
-1,627,753
| -58% | -$1.85M | 0.14% | 148 |
|
|
2025
Q2 | $2.68M | Buy |
2,830,659
+2,023,167
| +251% | +$1.31M | 0.19% | 60 |
|
|
2025
Q1 | $372K | Buy |
+807,492
| New | +$509K | 0.03% | 1003 |
|
|
2024
Q2 | – | Sell |
-293,333
| Closed | -$704K | – | 1874 |
|
|
2024
Q1 | $704K | Sell |
293,333
-486,744
| -62% | -$1.05M | 0.06% | 675 |
|
|
2023
Q4 | $1.19M | Buy |
+780,077
| New | +$928K | 0.1% | 304 |
|
|
2023
Q2 | – | Sell |
-69,791
| Closed | -$170K | – | 1758 |
|
|
2023
Q1 | $170K | Buy |
+69,791
| New | +$160K | 0.02% | 1288 |
|
|
2022
Q4 | – | Sell |
-71,004
| Closed | -$170K | – | 1706 |
|
|
2022
Q3 | $170K | Sell |
71,004
-300,594
| -81% | -$832K | 0.02% | 1277 |
|
|
2022
Q2 | $691K | Buy |
371,598
+141,095
| +61% | +$269K | 0.1% | 313 |
|
|
2022
Q1 | $482K | Buy |
230,503
+198,941
| +630% | +$551K | 0.06% | 555 |
|
|
2021
Q4 | $124K | Buy |
+31,562
| New | +$153K | 0.02% | 1297 |
|
|
2020
Q1 | – | Sell |
-179,481
| Closed | -$745K | – | 1340 |
|
|
2019
Q4 | $745K | Buy |
+179,481
| New | +$691K | 0.09% | 381 |
|
|
2019
Q3 | – | Sell |
-87,132
| Closed | -$548K | – | 1569 |
|
|
2019
Q2 | $548K | Buy |
87,132
+59,685
| +217% | +$357K | 0.06% | 611 |
|
|
2019
Q1 | $153K | Sell |
27,447
-29,139
| -51% | -$177K | 0.02% | 1284 |
|
|
2018
Q4 | $376K | Sell |
56,586
-18,000
| -24% | -$146K | 0.04% | 710 |
|
|
2018
Q3 | $796K | Buy |
74,586
+56,900
| +322% | +$652K | 0.04% | 823 |
|
|
2018
Q2 | $212K | Sell |
17,686
-32,600
| -65% | -$333K | 0.01% | 1516 |
|
|
2018
Q1 | $431K | Sell |
50,286
-23,800
| -32% | -$220K | 0.02% | 1141 |
|
|
2017
Q4 | $732K | Buy |
74,086
+23,300
| +46% | +$242K | 0.04% | 751 |
|
|
2017
Q3 | $624K | Buy |
50,786
+31,100
| +158% | +$459K | 0.04% | 830 |
|
|
2017
Q2 | $324K | Sell |
19,686
-72,700
| -79% | -$1.13M | 0.02% | 1228 |
|
|
2017
Q1 | $1.32M | Sell |
92,386
-52,950
| -36% | -$786K | 0.07% | 476 |
|
|
2016
Q4 | $2.01M | Buy |
145,336
+54,850
| +61% | +$880K | 0.12% | 202 |
|
|
2016
Q3 | $1.64M | Sell |
90,486
-13,094
| -13% | -$211K | 0.09% | 329 |
|
|
2016
Q2 | $1.49M | Buy |
103,580
+41,278
| +66% | +$560K | 0.08% | 387 |
|
|
2016
Q1 | $745K | Buy |
+62,302
| New | +$653K | 0.05% | 729 |
|
Other funds holding LXRX
AG
SL
SC
VCM
